Physician profile
David Denton
NPI 1861033177
$1,724.70
in general payments reported to CMS, 2019-2025
34 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $770 · 2022: $129 · 2023: $283 · 2024: $420 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $167.93 | 2021 | |
| Cranial Technologies, INC | $163.70 | 2022-2025 | Doc Band |
| Boston Scientific Corporation | $160.53 | 2021-2024 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16 |
| Abbvie INC. | $130.40 | 2021-2024 | |
| Pfizer INC. | $105.94 | 2021-2024 | |
| Biohaven Pharmaceuticals, INC. | $101.86 | 2021 | |
| Arbor Pharmaceuticals, INC. | $71.29 | 2021 | |
| Sanofi Pasteur INC. | $66.40 | 2022-2023 | |
| Corium, LLC | $53.21 | 2023-2024 | Azstarys |
| Nevro Corp. | $46.48 | 2021 | |
| Hologic Sales and Service, LLC | $45.14 | 2023 | Aptima |
| Novo Nordisk INC | $44.31 | 2022-2024 | Rybelsus, Ozempic |
| Stimwave Technologies Incorporated | $41.06 | 2021 | |
| Dexcom, INC. | $40.63 | 2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $35.27 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Illuminoss Medical, INC. | $34.08 | 2025 | |
| Glaxosmithkline, LLC. | $34.07 | 2022-2025 | Bexsero |
| Astrazeneca Pharmaceuticals LP | $32.55 | 2024 | Flumist Quadrivalent, Airsupra |
| Exact Sciences Corporation | $32.20 | 2025 | The Cologuard Plus Collection Kit |
| Eisai INC. | $31.08 | 2021 | |
| Seqirus USA INC | $30.67 | 2023-2024 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Supernus Pharmaceuticals, INC. | $29.46 | 2023 | Qelbree |
| Ironshore Pharmaceuticals INC. | $28.11 | 2024 | |
| Alk-Abello, INC | $27.30 | 2023 | Odactra, Ragwitek, Grastek |
| Inspire Medical Systems, INC. | $25.98 | 2023 | Inspire |
| Sun Pharmaceutical Industries INC. | $20.99 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $18.17 | 2025 | Austedo Xr |
| Horizon Therapeutics Plc | $17.46 | 2021 | |
| Alnylam Pharmaceuticals INC. | $17.25 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $17.21 | 2022 | |
| Neos Therapeutics, LP | $15.53 | 2024 | Cotempla Xr-Odt |
| Scilex Pharmaceuticals INC. | $15.38 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.34 | 2021 | |
| Genentech USA, INC. | $9.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Denton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.